Skip to content

XERSXERIS BIOPHARMA HOLDINGS INC

CUSIP 98422E103 · common stock

3 tracked investors held XERIS BIOPHARMA HOLDINGS INC (XERS) at the end of Q3 2026, worth $15.1M in total. The largest holder was Perceptive Advisors, with 0.2% of its portfolio.

Holders · Q3 2026
3
New holders
0
Value held
$15.1M
Quarter-end price (est.)
$9.56

Investors holding XERS · Q3 2026

InvestorWeightSharesValueChange
Perceptive Advisors
Perceptive Advisors LLC
0.16%933,671$8.9MADD+99.9%
Chuck Royce
Royce & Associates LP
0.05%588,178$5.6MADD+27.5%
Joel Greenblatt
Gotham Asset Management, LLC
0.00%62,452$597KREDUCE-49.6%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026300$15.1M$9.56
Q2 2026310$8.3M$7.92
Q1 2026211$1.7M$5.80
Q4 2025200$1.3M$7.85